Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis

Date Published

September 30, 2024

Denk A, Mittermaier C, Weber D, Fante M, Gunes S, Edinger M, Herr W, Wolff D. Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis. Ann Hematol. 2024 Sep. 103:3755-3764. doi:10.1007/s00277-024-05697-w. PMID: 38916742